AtomVie Global Radiopharma Inc.

Hamilton,  ON 
Canada
http://www.atomvie.com

• Booth: 1705

AtomVie Global Radiopharma Inc. is a leading CDMO for GMP manufacturing of radiotherapeutics for clinical, commercial supply and global distribution.

AtomVie Global Radiopharma (AtomVie) is a leading global CDMO specializing in GMP-compliant manufacturing and distribution of radiopharmaceuticals. AtomVie provides a comprehensive range of scientific, technical, regulatory, quality, and logistics expertise to support the development of your radiopharmaceuticals from Phase 1 to market. AtomVie is constructing a state-of-the-art, purpose-built, and scalable 72,300 sq. ft. cGMP facility, which will be ready by the end of 2025 for clinical and commercial-scale production of radiopharmaceuticals.

Brands: AtomVie Global Radiopharma Inc. offers the complete suite of capabilities, including the following: • Process and Analytical Method Development • Technology Transfer and Optimization • Scale-up and stability studies • Analytical and process validation • Logistics to global destinations (North America, EU, Asia, Australia and more) • Regulatory affairs (FDA, Health Canada, and EMA) • Routine clinical and commercial supply to meet the needs of our clients • Multiple partners for supply of radioisotopes

 Show Specials

• AtomVie Newsletter (Mar 21, 2025)
  Subscribe now for latest updates!

 Press Releases

• Eckert & Ziegler and AtomVie Global Radiopharma (Mar 21, 2025)

  Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply

 Products